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Abstract 
Amorphous solid dispersions (ASDs) refers to drug - carrier systems, where the 
drug is dispersed in the carrier at a molecular level. In this work, ASDs were 
formulated by spray drying. The aim was to achieve high drug loads of an 
amorphous hydrophobic drug (Efavirenz - EFV) in  the  carrier Soluplus®. Solid 
state characterizations (mDSC, XRPD, DVS, Raman, SEM, stability and 
solubility studies) were done. EFV amorphisation in ASDs (20 to 85% EFV 
loads) resulted in improved drug solubility compared to unprocessed EFV 
crystals and tendency of properties evolution over time for ASDs with EFV loads  
higher than 70 wt%. 
  
Keywords: amorphous solid dispersion, spray drying, high drug loading, 
soluplus, efavirenz. 
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1. Introduction 
Poorly water-soluble drugs have steadily grown on the global pharmaceutical industry. The 
technological approach focused on rendering the drug amorphous to improve apparent 
solubility remains a challenge since amorphous state is metastable in nature with a potential to 
undergo recrystallization [1]. In order to prevent this conversion, amorphous materials have 
been stabilized as solid dispersions using generally hydrophilic carriers for stabilization [2]. 
An amorphous solid dispersion (ASD) refers to drug–carrier systems in which the mechanism 
of drug dispersion is the key to understand its behavior. Such formulations impart an 
antiplasticizing effect on the amorphous compound yielding an increase in the glass transition 
temperature thereby reducing molecular mobility [3]. However, in order to achieve adequate 
stabilization, solid dispersions are often produced with a relatively low drug load (<30 wt%) 
dispersed in the carrier at molecular level. The problem is that a low drug-loaded ASD requires 
a large dose to ensure therapeutic efficacy. 
The insertion of high drug load formulations on the market is expected to meet patients demand 
for fixed, unique and smaller dosage combinations products. Furthermore, the supersaturated 
combinations may reduce dosage amounts as well as decrease the production in the 
pharmaceutical industries to supply cost savings. The aim of the current work was to generate,  
by spray drying, ASDs comprising a hydrophobic drug class II BCS (low solubility, good 
permeability for oral administration) in a hydrophilic carrier (Soluplus®-SOL) expecting to 
achieve drug loads higher than 40% w/w in the binary mixtures. The physical stability will be 
the critical control point. The drug of choice is Efavirenz (EFV). EFV is a non-nucleoside 
reverse transcriptase inhibitor used in the first-line treatment of HIV with low solubility (3-
9 μg/mL) and high permeability [4].   
2. Materials and Methods 
EFV was kindly supplied by Cristalia Ltd (Itapira, Brazil), SOL (polyvinyl caprolactam-
polyvynil acetate-polyethylene glycol) was obtained from BASF corporation (Ludwigshafen, 
Germany) and Ethanol (Carlo Erba, Italy) was used as organic solvent.  
The feeding solution was prepared by dissolving EFV in a 10 wt% solution of Soluplus in 
ethanol. Binary mixtures EFV-SOL containing from 20 to 85 wt% of EFV were formulated as 
spray-dried powders. The individual constituents (drug and polymer) were also spray-dried 
from ethanol solutions and used for comparison purposes. 
A Buchi B-290 minispray dryer (Buchi Labortechnik AG, Flawil, Switzerland) equipped with 
Inert Loop B-295 and an integrated two-fluid 0.7 mm nozzle was used to produce the ASD 
samples. Compressed nitrogen was used as the drying/carrying gas with a flow rate of 600 L/h. 
The solution feed rate was typically 3 g/min, the inlet temperature was set to 80±2 °C and the 
outlet temperature was maintained at 59±2 °C.  
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X-ray diffraction (XRD), modulated differential scanning calorimetry (mDSC), Raman 
spectroscopy, Scanning electron microscopy (SEM) and Infrared Spectroscopy (IR) were used 
to characterize the solid state of the spray-dried samples.  
Water sorption isotherms were determined gravimetrically using an automated dynamic water 
sorption analyzer (DVS). Samples were subjected to 0–95 % relative humidity (RH) sorption-
desorption cycle, over 10 % RH increments. For stability studies, samples were analyzed using 
DVS and exposed to stress conditions at 40 °C and 75 % RH during 15 days. Every 3 days, the 
samples were quickly analyzed by DSC to monitor changes in the physical state. 
Solubility studies of unprocessed EFV crystals and ASDs were carried out in duplicate. For 
that purpose, an excess amount of samples was added into 30 mL of a dissolution medium 
containing purified water plus 0.25 wt% of sodium lauryl sulfate (SLS) under agitation at 
37±0.5 °C in a water bath. The withdraws were collected from 5 min until 48 h. 
3. Results and discussion 
3.1. X-ray diffraction (XRD) 
The absence of Bragg peaks in X-ray diffractograms (Fig. 1) of all spray-dried solids indicates 
the complete loss of the crystalline structure of EFV, which becomes amorphous during the 
spray-drying process. 
3.2. Thermal analysis (mDSC) 
Thermal analysis was performed to investigate the apparent EFV-Soluplus® miscibility. Fig. 2 
shows the single experimental glass transition temperature (Tg) identified for pure contituents 
and for each binary mixture EFV- SOL loaded with 40, 60 and 85 wt% EFV. The 𝑇𝑇𝑔𝑔 of 
mixtures (Tgmix) are placed as an intermediary between the pure drug and polymer values and 
are close to the theoretical values of 𝑇𝑇𝑔𝑔 calculated by Gordon-Taylor (GT) equation (Equation 
1). This equation relates the individual contributions of each component in an ideal mixture 
(with no interactions between the components). 
𝑻𝑻𝒎𝒎𝒎𝒎𝒎𝒎
𝒈𝒈 = 𝑾𝑾𝑷𝑷𝑷𝑷 .𝑻𝑻𝑷𝑷𝑷𝑷𝒈𝒈 + 𝑲𝑲.(𝟏𝟏−𝑾𝑾𝑷𝑷𝑷𝑷).𝑻𝑻𝑷𝑷𝑷𝑷𝒈𝒈
𝑾𝑾𝑷𝑷𝑷𝑷+𝑲𝑲.(𝟏𝟏−𝑾𝑾𝑷𝑷𝑷𝑷)      (1) 
𝑻𝑻𝑷𝑷𝑷𝑷
𝒈𝒈  and 𝑻𝑻𝑷𝑷𝑷𝑷
𝒈𝒈  are the drug and polymer glass transition temperatures (K), respectively. 𝑾𝑾𝑷𝑷𝑷𝑷 is 
the drug mass fraction in the mixture. K is defined as fitting parameter characterizing the 
curvature of the evolution and is defined by equation 2 [5].  
𝑲𝑲 =  𝑻𝑻𝑷𝑷𝑷𝑷𝒈𝒈  .𝝆𝝆𝑷𝑷𝑷𝑷
𝑻𝑻𝑷𝑷𝑷𝑷
𝒈𝒈 .𝝆𝝆𝑷𝑷𝑷𝑷       (2) 
Densities (g/cm3), determined by helium picnometry, 𝝆𝝆𝑷𝑷𝑷𝑷 and 𝝆𝝆𝑷𝑷𝑷𝑷, are 1.39 and 1.18, 
respectively.  
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According to XRD and DSC results, an amorphous solid dispersions of EFV- SOL seems to 
be formed during the spray-drying process. 
 
Fig. 1 XRD diffractograms of: (1) pure EFV; (2) pure SOL; (3) 40 % EFV; (4) 60 % EFV and (5) 
85 % EFV. 
 
 
Fig. 2 Glass transition temperature (Tgmix): measured (blue circles) and theoretical values by GT 
equation (dotted red line). 
 
3.3. Raman microscopy 
Raman microscopy was also performed for three EFV-SOL ASD (Fig. 3). They were evaluated 
by observing the characteristic peaks of pure drug (peak at 2250 cm-1) and pure polymer (peak 
at 2900 cm-1). As expected, the increase of the drug load in the mixture corresponded to a more 
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intense characteristic EFV peak. The presence of characteristic peaks of pure components in 
all ASD Raman spectra shows the absence of specific interactions between the two components 
and confirms the ideal mixing suggested by the evolution of the mixtures 𝑇𝑇𝑔𝑔  and SOL for all 
studied drug loads. 
 
Fig. 3 Raman spectra for the EFV-SOL ASD with different drug loads: 40%; 60%; 85% EFV. 
 
3.4. Scanning electron microscopy (SEM) 
SEM images of the spray-dried powders are shown in Fig. 4. ASD EFV-SOL particles are 
predominantly spherical and different in shape from both original constituants that are the 
unprocessed EFV crystals (Fig. 4B - long rods with regular and organized multi-face geometry) 
and the spray-dried polymer (Fig. 4A - wrinkled particles). A good mixing between both 
compounds could led to these apparently homogeneous solid particles. 
3.5. Stability studies 
Fig. 5 displays the DVS isotherm plots for the studied samples, showing the change in mass 
percentage as a function of changing relative humidity. The reversibility of the water uptake 
was clearly seen in all cases. Taking as example the curves at 75 % RH (Fig. 5B), the tendency 
of increasing the hydrophobic character of EFV-SOL ASD by increasing the EFV load is 
demonstrated. The decreased affinity to water with increased drug load could be an interesting 
attribute for the physical stability of the amorphous drug phase in high drug load ASDs. 
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Fig. 4 SEM images of spray-dried ASD constituted by a EFV-SOL binary mixture. 
 
 
Fig. 5 A) DVS isotherms for 1- pure SOL; 2- 40% EFV; 3- 60%  EFV; 4- 85% EFV; 5- pure EFV. 
B) Water mass change (%) at 75%RH for the ASD. 
The stability results under stress conditions are presented in Table 1. It is noticeable that the 
samples have evolved over time since Tgmix increases in both cases, suggesting a variation in 
the amorphous mixture composition. However, we did not observe any particular signs of 
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amorphous phase separation or drug recrystallisation for the sample loaded with 40 % EFV. 
Contrarily, 70 % EFV-SOL ASD revealed an evolution of crystallization enthalpy (ΔH) over 
time, corresponding to a partial EFV recrystallization. This tendance for recrystallization can 
be attributed to the high drug load of the ASD, probably corresponding to a supersaturated (and 
instable) amorphous state of the drug. Considering ΔH=52.83 J/g for the unprocessed EFV 
crystals, it was possible to estimate the percentage of drug recrystallizing in this ASD during 
storage. Table 1 also shows that, after 15 days of storage, approximately 6.6 % of the 
amorphous EFV dispersed in Soluplus recrystallized. 
3.6. Solubility studies 
In Figure 6, the results showed that spray-dried EFV- SOL ASDs produced with 20, 40 and 60 
wt% EFV presented a good solubility enhancement in comparison with the unprocessed EFV 
crystals. EFV- SOL ASDs solubility decreases gradually with drug load increasing in the spray-
dried powders. Indeed, EFV- SOL ASD with 20wt% EFV exhibited the maximum apparent 
EFV solubility over approximately 36h in simulated intestinal fluid. 
Table 1. Stability results under stress conditions (40 °C/75 % RH) 
 for EFV-SOL ASD with drug loads of 40 % and 70 % 
 40 % EFV-SOL 70 % EFV-SOL 
t (days)  𝑻𝑻𝒎𝒎𝒎𝒎𝒎𝒎
𝒈𝒈  (°𝑪𝑪) 𝑻𝑻𝒎𝒎𝒎𝒎𝒎𝒎𝒈𝒈  (°𝑪𝑪) Crystallization enthalpy  
ΔH (J/g) 
  
Crystallization  
(%) 
3 59.8 51.4 1.3 2.4 
6 64.9 53.4 2.6 4.9 
9 64.1 55.9 2.8 5.3 
15 67.2 57.7 3.5 6.6 
 
4. Conclusions 
A robust formulation with optimal drug load and excipients is one of the key factors of 
successfully developing an ASD system. In this work, amorphous solid dispersions of the 
poorly water soluble compound Efavirenz were prepared with drug loads in the range 20 to 
85 wt% EFV, using Soluplus® as hydrophilic carrier and spray drying as the production 
process. Solubility tests revealed a good solubility enhancement for all ASD compared with 
crystalline drug solubility. To the best of our knowledge, it is the first study reporting such 
high levels of drug loading (up to 85 wt%) in supersaturated amorphous solid dispersions of 
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EFV. However, our results also showed that the physical stability should be a monitoring 
critical point for EFV-SOL ASDs with EFV loads higher thanv 70 wt% EFV. 
 
Fig. 6 Kinetic solubility of spray-dried EFV-SOL ASD. 
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